AnaptysBio Inc $ 35.98 2.13 (6.29%)
Volume:
245,934
Avg Vol (1m):
333,002
Market Cap $:
973.17 Mil
Enterprise Value $:
555.75 Mil
P/E (TTM):
0.00
P/B:
2.17
Manual of Stocks™ Web
Financial Strength | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 88.31 | ||
| Equity-to-Asset | 0.93 | ||
| Debt-to-Equity | 0.01 | ||
| Debt-to-EBITDA | -0.06 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 17.85 | ||
| Beneish M-Score | -0.53 | ||
Profitability | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -879.79 | ||
| Net Margin % | -789.92 | ||
| ROE % | -18.05 | ||
| ROA % | -17.08 | ||
| ROC (Joel Greenblatt) % | -5612.18 | ||
| 3-Year Revenue Growth Rate | -44.3 | ||
| 3-Year EBITDA Growth Rate | -100.3 | ||
| 3-Year EPS without NRI Growth Rate | -72.2 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 2.17 | ||
| PS Ratio | 91.78 | ||
| EV-to-EBIT | -7.14 | ||
| EV-to-EBITDA | -7.19 | ||
| EV-to-Revenue | 55.58 | ||
| Current Ratio | 14.07 | ||
| Quick Ratio | 14.07 | ||
| Days Sales Outstanding | 182.5 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.1 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 2.17 | ||
| Price-to-Median-PS-Value | 0.47 | ||
| Earnings Yield (Greenblatt) % | -14.02 |